Sarah W. Read

Therapy for Early COVID-19

Peter Kim, Sarah W. Read, Anthony S. Fauci · JAMA · 2020 · 133 citations

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +8

CD4 ⁺ T Cells, Including Th17 and Cycling Subsets, Are Intact in the Gut Mucosa of HIV-1-Infected Long-Term Nonprogressors

Emily J. Ciccone, Jamieson H. Greenwald, Philip I. Lee et al. · Journal of Virology · 2011 · 91 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Sevelamer Does Not Decrease Lipopolysaccharide or Soluble CD14 Levels But Decreases Soluble Tissue Factor, Low-Density Lipoprotein (LDL) Cholesterol, and Oxidized LDL Cholesterol Levels in Individuals With Untreated HIV Infection

Netanya G. Sandler, Xinyan Zhang, Ronald J. Bosch et al. · The Journal of Infectious Diseases · 2014 · 82 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Rifaximin has a Marginal Impact on Microbial Translocation, T-cell Activation and Inflammation in HIV-Positive Immune Non-responders to Antiretroviral Therapy – ACTG A5286

Allan R. Tenorio, Ellen S. Chan, Ronald J. Bosch et al. · The Journal of Infectious Diseases · 2014 · 79 citations · Full text

Medicine, Immunology, Pharmacology +15

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics

Lisa M. LaVange, Stacey J. Adam, Judith S. Currier et al. · Annals of Internal Medicine · 2021 · 61 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17